• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌基因EVI1增强人髓细胞对全反式维甲酸的转录和生物学反应。

The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid.

作者信息

Steinmetz Birgit, Hackl Hubert, Slabáková Eva, Schwarzinger Ilse, Smějová Monika, Spittler Andreas, Arbesu Itziar, Shehata Medhat, Souček Karel, Wieser Rotraud

机构信息

a Department of Medicine I ; Medical University of Vienna ; Währinger Gürtel, Vienna , Austria.

出版信息

Cell Cycle. 2014;13(18):2931-43. doi: 10.4161/15384101.2014.946869.

DOI:10.4161/15384101.2014.946869
PMID:25486480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4613657/
Abstract

The product of the ecotropic virus integration site 1 (EVI1) gene, whose overexpression is associated with a poor prognosis in myeloid leukemias and some epithelial tumors, regulates gene transcription both through direct DNA binding and through modulation of the activity of other sequence specific transcription factors. Previous results from our laboratory have shown that EVI1 influenced transcription regulation in response to the myeloid differentiation inducing agent, all-trans retinoic acid (ATRA), in a dual manner: it enhanced ATRA induced transcription of the RARβ gene, but repressed the ATRA induction of the EVI1 gene itself. In the present study, we asked whether EVI1 would modulate the ATRA regulation of a larger number of genes, as well as biological responses to this agent, in human myeloid cells. U937 and HL-60 cells ectopically expressing EVI1 through retroviral transduction were subjected to microarray based gene expression analysis, and to assays measuring cellular proliferation, differentiation, and apoptosis. These experiments showed that EVI1 modulated the ATRA response of several dozens of genes, and in fact reinforced it in the vast majority of cases. A particularly strong synergy between EVI1 and ATRA was observed for GDF15, which codes for a member of the TGF-β superfamily of cytokines. In line with the gene expression results, EVI1 enhanced cell cycle arrest, differentiation, and apoptosis in response to ATRA, and knockdown of GDF15 counteracted some of these effects. The potential clinical implications of these findings are discussed.

摘要

嗜亲性病毒整合位点1(EVI1)基因的产物在髓系白血病和一些上皮肿瘤中过表达与预后不良相关,它通过直接结合DNA以及调节其他序列特异性转录因子的活性来调控基因转录。我们实验室之前的研究结果表明,EVI1以双重方式影响对髓系分化诱导剂全反式维甲酸(ATRA)的转录调控:它增强了ATRA诱导的RARβ基因转录,但抑制了EVI1基因本身的ATRA诱导。在本研究中,我们探究了EVI1是否会调节人类髓系细胞中更多基因的ATRA调控以及对该试剂的生物学反应。通过逆转录病毒转导异位表达EVI1的U937和HL-60细胞进行了基于微阵列的基因表达分析,并进行了测量细胞增殖、分化和凋亡的实验。这些实验表明,EVI1调节了几十个基因的ATRA反应,并且实际上在绝大多数情况下增强了该反应。对于编码细胞因子TGF-β超家族成员的GDF15,观察到EVI1与ATRA之间有特别强的协同作用。与基因表达结果一致,EVI1增强了对ATRA的细胞周期阻滞、分化和凋亡,并且敲低GDF15抵消了其中一些作用。讨论了这些发现的潜在临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/50d32321360f/kccy-13-18-946869-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/cb9a91bcd3d4/kccy-13-18-946869-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/80c4abdbc740/kccy-13-18-946869-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/21c6538f4020/kccy-13-18-946869-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/da6d13e6a41d/kccy-13-18-946869-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/86191d2f70a8/kccy-13-18-946869-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/2e645aa9ab9c/kccy-13-18-946869-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/50d32321360f/kccy-13-18-946869-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/cb9a91bcd3d4/kccy-13-18-946869-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/80c4abdbc740/kccy-13-18-946869-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/21c6538f4020/kccy-13-18-946869-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/da6d13e6a41d/kccy-13-18-946869-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/86191d2f70a8/kccy-13-18-946869-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/2e645aa9ab9c/kccy-13-18-946869-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2970/4613657/50d32321360f/kccy-13-18-946869-g007.jpg

相似文献

1
The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid.致癌基因EVI1增强人髓细胞对全反式维甲酸的转录和生物学反应。
Cell Cycle. 2014;13(18):2931-43. doi: 10.4161/15384101.2014.946869.
2
EVI1 promotes tumor growth via transcriptional repression of MS4A3.EVI1通过对MS4A3的转录抑制来促进肿瘤生长。
J Hematol Oncol. 2015 Mar 21;8:28. doi: 10.1186/s13045-015-0124-6.
3
Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.锌指基因EVI-1在急性早幼粒细胞白血病中的表达。
Leukemia. 1997 Feb;11(2):212-20. doi: 10.1038/sj.leu.2400547.
4
Zinc finger transcription factor ecotropic viral integration site 1 is induced by all-trans retinoic acid (ATRA) and acts as a dual modulator of the ATRA response.锌指转录因子 ecotropic 病毒整合位点 1 被全反式视黄酸(ATRA)诱导,作为 ATRA 反应的双重调节剂。
FEBS J. 2009 Nov;276(22):6810-22. doi: 10.1111/j.1742-4658.2009.07398.x. Epub 2009 Oct 16.
5
Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acid.过表达 EVI-1 的原发性急性髓系白血病细胞对全反式维甲酸敏感。
Blood. 2016 Jan 28;127(4):458-63. doi: 10.1182/blood-2015-07-653840. Epub 2015 Nov 18.
6
All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.全反式维甲酸增强了 EVI1 在急性髓系白血病中的干细胞促进活性,而 pan-RAR 拮抗剂则与之相反。
Cell Death Dis. 2019 Dec 10;10(12):944. doi: 10.1038/s41419-019-2172-2.
7
EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells.EVI1 通过上调人髓细胞中的 CDKN1A/p21/WAF 抑制抗白血病药物诱导的细胞凋亡。
PLoS One. 2013;8(2):e56308. doi: 10.1371/journal.pone.0056308. Epub 2013 Feb 14.
8
Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor.罗司戊醇增强全反式维甲酸(ATRA)诱导的白血病细胞分化:对潜在的细胞周期蛋白依赖性激酶 2 抑制剂信号分子的新作用。
Cell Signal. 2020 Jul;71:109555. doi: 10.1016/j.cellsig.2020.109555. Epub 2020 Feb 4.
9
Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes.EVI1在人髓系细胞中的可诱导表达导致的表型与其在骨髓增生异常综合征中的作用一致。
J Leukoc Biol. 2009 Oct;86(4):813-22. doi: 10.1189/jlb.0109042. Epub 2009 Jul 15.
10
Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression.嗜亲性病毒整合位点-1基因在骨髓增生异常综合征后急性髓系白血病中优先表达:可能与GATA-1、GATA-2和干细胞白血病基因表达相关。
Blood. 1995 Jun 15;85(12):3713-8.

引用本文的文献

1
Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy.脑肾上腺脑白质营养不良基因治疗后的血液系统癌症。
N Engl J Med. 2024 Oct 10;391(14):1287-1301. doi: 10.1056/NEJMoa2405541.
2
The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away.维甲酸在癌症治疗中的前景:并非日薄西山,亦非渐趋式微。
Cancers (Basel). 2023 Jul 8;15(14):3535. doi: 10.3390/cancers15143535.
3
Differentiation therapy for myeloid malignancies: beyond cytotoxicity.髓系恶性肿瘤的分化治疗:超越细胞毒性。

本文引用的文献

1
An optimized microRNA backbone for effective single-copy RNAi.一种优化的 miRNA 骨架,可实现有效的单拷贝 RNAi。
Cell Rep. 2013 Dec 26;5(6):1704-13. doi: 10.1016/j.celrep.2013.11.020. Epub 2013 Dec 12.
2
Retinoic acid signaling is essential for embryonic hematopoietic stem cell development.视黄酸信号对于胚胎造血干细胞的发育是必不可少的。
Cell. 2013 Sep 26;155(1):215-27. doi: 10.1016/j.cell.2013.08.055.
3
High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group.
Blood Cancer J. 2021 Dec 4;11(12):193. doi: 10.1038/s41408-021-00584-3.
4
High Expression Predicts Adverse Outcomes in Children With Acute Myeloid Leukemia.高表达预示急性髓系白血病患儿的不良预后。
Front Oncol. 2021 Sep 13;11:712747. doi: 10.3389/fonc.2021.712747. eCollection 2021.
5
Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia-Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation.丙戊酸和全反式维甲酸在急性髓系白血病中的治疗应用——文献综述及异基因干细胞移植后复发时可能应用的探讨
Pharmaceuticals (Basel). 2021 May 2;14(5):423. doi: 10.3390/ph14050423.
6
Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of Retinoic Acid on -ITD/-Driven Acute Myeloid Leukemia Cells.抵消视黄酸对-ITD/-驱动的急性髓系白血病细胞的抗白血病和干细胞抑制作用。
Biomedicines. 2020 Sep 28;8(10):385. doi: 10.3390/biomedicines8100385.
7
retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells.维甲酸在非早幼粒细胞性急性髓细胞白血病中的作用:驱动病变对白血病干细胞的影响。
Cell Cycle. 2020 Oct;19(20):2573-2588. doi: 10.1080/15384101.2020.1810402. Epub 2020 Sep 8.
8
Effects of matrine on the proliferation and apoptosis of vincristine-resistant retinoblastoma cells.苦参碱对长春新碱耐药视网膜母细胞瘤细胞增殖和凋亡的影响。
Exp Ther Med. 2020 Sep;20(3):2838-2844. doi: 10.3892/etm.2020.8992. Epub 2020 Jul 13.
9
Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1.全反式维甲酸对EVI1过表达的高危急性髓系白血病的疗效
Oncol Ther. 2019 Dec;7(2):121-130. doi: 10.1007/s40487-019-0095-9. Epub 2019 May 22.
10
All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.全反式维甲酸增强了 EVI1 在急性髓系白血病中的干细胞促进活性,而 pan-RAR 拮抗剂则与之相反。
Cell Death Dis. 2019 Dec 10;10(12):944. doi: 10.1038/s41419-019-2172-2.
EVI1 高表达与 MLL 重排相关,并预示着儿科急性髓系白血病患者生存时间缩短:来自儿童肿瘤协作组的报告。
Br J Haematol. 2013 Sep;162(5):670-7. doi: 10.1111/bjh.12444. Epub 2013 Jul 4.
4
Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia.急性髓系白血病中EVI1靶基因的全基因组鉴定
PLoS One. 2013 Jun 27;8(6):e67134. doi: 10.1371/journal.pone.0067134. Print 2013.
5
EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis.EVI1 癌基因通过抑制 microRNA-96 促进胰腺发生中的 KRAS 通路。
Oncogene. 2014 May 8;33(19):2454-63. doi: 10.1038/onc.2013.204. Epub 2013 Jun 10.
6
EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.EVI1 靶向 ΔNp63 并上调细胞周期蛋白依赖性激酶抑制剂 p21,而不依赖于 p53,以延缓结肠癌细胞的细胞周期进程和增殖。
Int J Biochem Cell Biol. 2013 Aug;45(8):1568-76. doi: 10.1016/j.biocel.2013.04.032. Epub 2013 May 9.
7
EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells.EVI1 通过上调人髓细胞中的 CDKN1A/p21/WAF 抑制抗白血病药物诱导的细胞凋亡。
PLoS One. 2013;8(2):e56308. doi: 10.1371/journal.pone.0056308. Epub 2013 Feb 14.
8
Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells.Evi1 的激活抑制造血祖细胞的细胞周期进程和分化。
Leukemia. 2013 Apr;27(5):1127-38. doi: 10.1038/leu.2012.355. Epub 2012 Dec 5.
9
EVI1 and MDS1/EVI1 expression during primary human hematopoietic progenitor cell differentiation into various myeloid lineages.EVI1 和 MDS1/EVI1 在原代人造血祖细胞向各种髓系谱系分化过程中的表达。
Anticancer Res. 2012 Nov;32(11):4883-9.
10
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.EVI1 表达失调定义了伴有 MLL 重排的急性髓系白血病预后不良的亚群:德国-奥地利急性髓系白血病研究组和荷兰-比利时-瑞士 HOVON/SAKK 合作组的研究。
J Clin Oncol. 2013 Jan 1;31(1):95-103. doi: 10.1200/JCO.2011.41.5505. Epub 2012 Sep 24.